SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-20-000115
Filing Date
2020-08-05
Accepted
2020-08-05 17:17:11
Documents
61
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS INC 10-Q 6-30-2020 form10q.htm   iXBRL 10-Q 2711698
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 6537
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 42752
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 13545
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 13394
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 6948
  Complete submission text file 0000874015-20-000115.txt   10677483

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ions-20200630.xsd EX-101.SCH 46977
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20200630_cal.xml EX-101.CAL 68911
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20200630_def.xml EX-101.DEF 301998
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20200630_lab.xml EX-101.LAB 717001
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20200630_pre.xml EX-101.PRE 413462
12 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 2334808
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 201078616
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences